default search action

combined dblp search
author search
venue search
publication search

ask others

Nature, Volume 477

> Home > Journals > Nature

Refine list

refinements active!

zoomed in on ?? of ?? records

view refined list in

export refined list as

showing all ?? records

Volume 477, Number 7362, September 2011

- view
  authority control:
- export record
  dblp key:
  - journals/nature/Deeks11
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/nature/Deeks11
Steven G. Deeks:
HIV: How to escape treatment. 36-37
- view
  authority control:
- export record
  dblp key:
  - journals/nature/SigalKBDMMB11
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/nature/SigalKBDMMB11
Alex Sigal, Jocelyn T. Kim, Alejandro B. Balazs, Erez Dekel, Avi E. Mayo, Ron Milo, David Baltimore:
Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy. 95-98

Volume 477, Number 7364, September 2011

- view
  authority control:
- export record
  dblp key:
  - journals/nature/Lok11
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/nature/Lok11
Corie Lok:
Biomedical illustration: From monsters to molecules. 359-361

Volume 477, Number 7365, September 2011

- view
  authority control:
- export record
  dblp key:
  - journals/nature/Cressey11
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/nature/Cressey11
Daniel Cressey:
Q&A: The virtual trainer. 406

Volume 477, Number 7366, September 2011

- view
  authority control:
- export record
  dblp key:
  - journals/nature/Mitchinson11
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/nature/Mitchinson11
Andrew Mitchinson:
Q&A: Digital diva. 537

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.